Looking back on therapeutics stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Gilead Sciences (NASDAQ:GILD) and its peers.

Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...

The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed Blackstone Life Sciences VI (BXLS VI) at its hard cap of $6.3 billion in ...

Let’s explore the implications of this clinical achievement for Kodiak’s market position, the calculations behind its current valuation discrepancy, and ...

Anthropic is launching Claude for Life Sciences, a new model aimed at aiding scientific research. Through integrations with leading life sciences players, the platform will help researchers at every ...

The labs are not all right. After years of new supply without the tenant demand to support it, life sciences real estate nationwide is at an inflection point, with 18.7M SF likely to change uses by ...

The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...

The Earth sciences will become increasingly prominent in the 21st century as humanity confronts daunting challenges in finding natural resources to sustain Earth’s burgeoning population, in mitigating ...

Partnership brings Agri AI, factory intelligence and energy optimization into focus for one of India’s key growth sectors Findability Sciences has partnered with Sugar, Ethanol & Bioenergy India ...